Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Docetaxel vs non‐docetaxel‐containing regimens

Progression‐free survival (PSF) · people with advanced gastric cancer

It is very uncertain whether docetaxel changes progression‐free survival ‐ Other comparison compared with non‐docetaxel‐containing regimens (very low certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
HR 0.94 [0.55, 1.6]
1 study · 56 participants
Very low